7. “Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)” has already finished recruitment and is ongoing at the Celgene Corporation.
See which clinical trials are currently recruiting here.